Skip to main content
main-content

Zeitschrift

Cancer Chemotherapy and Pharmacology

Cancer Chemotherapy and Pharmacology 5/2019

Ausgabe 5/2019

Inhaltsverzeichnis ( 21 Artikel )

31.07.2019 | Review Article | Ausgabe 5/2019

The thioredoxin system and cancer therapy: a review

Fariba Mohammadi, Arash Soltani, Atefeh Ghahremanloo, Hossein Javid, Seyed Isaac Hashemy

07.08.2019 | Review Article | Ausgabe 5/2019

Prodrugs as drug delivery system in oncology

J. Delahousse, C. Skarbek, A. Paci

04.09.2019 | Review Article | Ausgabe 5/2019

Polymorphisms of genes encoding drug transporters or cytochrome P450 enzymes and association with clinical response in cancer patients: a systematic review

Inthuorn Kulma, Kanyarat Boonprasert, Kesara Na-Bangchang

29.08.2019 | Original Article | Ausgabe 5/2019

Exposure–response analysis to inform the optimal dose of veliparib in combination with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer patients

Silpa Nuthalapati, Sven Stodtmann, Stacie Peacock Shepherd, Christine K. Ratajczak, Sven Mensing, Rajeev Menon, Hao Xiong

03.09.2019 | Original Article | Ausgabe 5/2019

Optimal dose of sunitinib for long-term treatment in Japanese patients with renal cell carcinoma

Yuto Yamada, Yuta Ohno, Yu Kato, Ryo Kobayashi, Hideki Hayashi, Shiho Miyahara, Keita Nakane, Kosuke Mizutani, Shigeaki Yokoi, Hironori Fujii, Hirotoshi Iihara, Takuma Ishihara, Takashi Deguchi, Tadashi Sugiyama, Akio Suzuki

03.09.2019 | Original Article | Ausgabe 5/2019

Population pharmacokinetics of siltuximab: impact of disease state

Mina Nikanjam, Jin Yang, Edmund V. Capparelli

03.09.2019 | Original Article | Ausgabe 5/2019

Population pharmacokinetics and exposure–overall survival analysis of the transforming growth factor-β inhibitor galunisertib in patients with pancreatic cancer

Ivelina Gueorguieva, Josep Tabernero, Davide Melisi, Teresa Macarulla, Valeria Merz, Timothy H. Waterhouse, Colin Miles, Michael M. Lahn, Ann Cleverly, Karim A. Benhadji

03.09.2019 | Original Article | Ausgabe 5/2019 Open Access

Evaluation of the potential for QTc prolongation with avelumab

Yulia Vugmeyster, Gülseren Güzel, Meliessa Hennessy, Anja H. Loos, Haiqing Dai

03.09.2019 | Original Article | Ausgabe 5/2019

Phase I trial of pimasertib monotherapy in Japanese patients with solid tumors and those with hepatocellular carcinoma

K. Yamazaki, T. Doi, M. Ikeda, T. Okusaka, A. Schueler, M. Watanabe, A. Ohtsu

04.09.2019 | Original Article | Ausgabe 5/2019

Serum microRNA-21 predicted treatment outcome and survival in HER2-positive breast cancer patients receiving neoadjuvant chemotherapy combined with trastuzumab

Baoquan Liu, Fei Su, Xiaohong Lv, Wenbo Zhang, Xiaochen Shang, Yafang Zhang, Jianguo Zhang

04.09.2019 | Original Article | Ausgabe 5/2019

Real-world data on initial treatment strategies for older adult patients with endometrial cancer in Japan

Mayu Yunokawa, Shinsuke Sasada, Yae Takehara, Kenta Takahashi, Tatsunori Shimoi, Kan Yonemori, Mitsuya Ishikawa, Tomoyasu Kato, Kenji Tamura

05.09.2019 | Original Article | Ausgabe 5/2019

Dose escalation study of amrubicin and cisplatin with concurrent thoracic radiotherapy for limited-disease small cell lung cancer

Midori Shimada, Hiroyuki Yamaguchi, Minoru Fukuda, Hiromi Tomono, Noritaka Honda, Yosuke Dotsu, Hirokazu Taniguchi, Hiroshi Gyotoku, Hiroaki Senju, Shinnosuke Takemoto, Takaya Ikeda, Katsumi Nakatomi, Yoichi Nakamura, Seiji Nagashima, Takuya Yamazaki, Hiroshi Mukae

06.09.2019 | Original Article | Ausgabe 5/2019

A phase II trial of induction of erlotinib followed by cytotoxic chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer patients

Tetsuo Tani, Katsuhiko Naoki, Hiroyuki Yasuda, Daisuke Arai, Kota Ishioka, Keiko Ohgino, Satoshi Yoda, Sohei Nakayama, Ryosuke Satomi, Hideki Terai, Shinnosuke Ikemura, Takashi Sato, Kenzo Soejima

06.09.2019 | Original Article | Ausgabe 5/2019

Development of a physiologically based pharmacokinetic model for intravenous lenalidomide in mice

Jim H. Hughes, Richard N. Upton, Stephanie E. Reuter, Darlene M. Rozewski, Mitch A. Phelps, David J. R. Foster

06.09.2019 | Original Article | Ausgabe 5/2019

Italian survey on cetuximab-based therapy of elderly patients with metastatic colorectal cancer

Gerardo Rosati, Raffaele Addeo, Giuseppe Aprile, Antonio Avallone, Domenico Bilancia, Silvia Brugnatelli, Gabriella Buccafusca, Chiara Carlomagno, Stefano Cordio, Sara Delfanti, Emanuela Dell’Aquila, Maurizio Di Bisceglie, Samantha Di Donato, Antonio Di Stasi, Domenico Germano, Francesco Giuliani, Cristina Granetto, Tiziana Pia Latiano, Silvana Leo, Paolo Tralongo, Maria Elena Stroppolo, Filippo Venturini, Salvatore Bianco

09.09.2019 | Original Article | Ausgabe 5/2019

Adverse event profiles of ifosfamide-induced encephalopathy analyzed using the Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases

Kazuyo Shimada, Shiori Hasegawa, Satoshi Nakao, Ririka Mukai, Kiyoka Matsumoto, Mizuki Tanaka, Hiroaki Uranishi, Mayuko Masuta, Shohei Nishida, Shinya Shimizu, Yuichi Hayashi, Akio Suzuki, Mitsuhiro Nakamura

09.09.2019 | Original Article | Ausgabe 5/2019

Prophylactic administration of granulocyte colony-stimulating factor in epirubicin and cyclophosphamide chemotherapy for Japanese breast cancer patients: a retrospective study

Takumi Sakurada, Sanako Bando, Yoshito Zamami, Kenshi Takechi, Masayuki Chuma, Mitsuhiro Goda, Yasushi Kirino, Toshimi Nakamura, Kazuhiko Teraoka, Masami Morimoto, Akira Tangoku, Keisuke Ishizawa

09.09.2019 | Original Article | Ausgabe 5/2019

A phase I study evaluating combined nimotuzumab and neoadjuvant chemoradiotherapy followed by surgery in locally advanced esophageal cancer

Saichun Qi, Ya Mao, Mingjun Jiang

11.09.2019 | Original Article | Ausgabe 5/2019

Pharmacokinetics and safety of neratinib during co-administration with loperamide in healthy subjects

Kiana Keyvanjah, Blaire Cooke, David Martin, Daniel Di Primeo, Laura Sterling, Jane Liang, Elizabeth Olek, Igor Rubets, Alvin Wong

12.09.2019 | Original Article | Ausgabe 5/2019

Downregulation of SRSF3 by antisense oligonucleotides sensitizes oral squamous cell carcinoma and breast cancer cells to paclitaxel treatment

Yanan Sun, Lingyan Yan, Jihua Guo, Jun Shao, Rong Jia

19.09.2019 | Clinical Trial Report | Ausgabe 5/2019

A phase I study of HER1, HER2 dual kinase inhibitor lapatinib plus the proteasome inhibitor bortezomib in patients with advanced malignancies

Filipa Lynce, Hongkun Wang, Emanuel F. Petricoin, Paula R. Pohlmann, Brandon Smaglo, Jimmy Hwang, Aiwu R. He, Deepa S. Subramaniam, John Deeken, John Marshall, Michael J. Pishvaian

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise